Background: Medical physicists are essential members of the radiation oncology team. Given the increasing complexity of radiotherapy delivery, it is important to ensure adequate training and staffing. The aim of the present study was to update a similar survey from 2008 and assess the situation of medical physicists in the large and diverse Asia Pacific region.
Before clinical use of a brachytherapy source, regulations or recommendations by medical physics societies require an independent measurement of its air kerma strength by a qualified medical physicist. Currently, in addition to Ir-192, also HDR-Co-60 sources are increasingly coming into operation. However, the existing dosimetry protocols do not provide any guidelines for Co-60 sources. The purpose of this work was therefore to compare air kerma rate measurements as recommended by different dosimetry protocols for Ir-192 HDR sources and to test their applicability to Co-60 sources. Dosimetric verification of HDR afterloading source specification was performed according to three protocols, DIN 6809-2 (1993) in combination with DGMP-Report 13 (2006), IAEA-TECDOC-1274 (2002) and AAPM Report 41 (1993) for the nuclides Ir-192 and Co-60. Measurements of the sources reference air kerma rate were performed with 3 different methods (with a cylindrical chamber both in a solid phantom and in free air, and with a well chamber) and evaluated using all three protocols for each type of source and method of measurement. The measurements with all protocols and methods show deviations from the certified specification smaller than about 1.2% for Ir-192 and 2.5% for Co-60-Sources. The measurements with the well chamber showed the lowest deviations from the certificate value. Air kerma rate measurements for Co-60 HDR sources using the existing protocols are possible with accuracy sufficient to verify source calibration as provided by the source certificate. However, extension of the protocols by correction factors for measurement with Co-60 sources would be helpful.
The history of medical physics in Asia-Oceania goes back to the late nineteenth century when X-ray imaging was introduced, although medical physicists were not appointed until much later. Medical physics developed very quickly in some countries, but in others the socio-economic situation as such prevented it being established for many years. In others, the political situation and war has impeded its development. In many countries their medical physics history has not been well recorded and there is a danger that it will be lost to future generations. In this paper, brief histories of the development of medical physics in most countries in Asia-Oceania are presented by a large number of authors to serve as a record. The histories are necessarily brief; otherwise the paper would quickly turn into a book of hundreds of pages. The emphasis in each history as recorded here varies as the focus and culture of the countries as well as the length of their histories varies considerably.
AimThe purpose of this study was to develop the patient-specific quality control (QC) process by most commonly used dosimeters in Bangladesh and recommend a suitable passing rate for QC, irrespective of the dosimetric tools used.Materials and methodsIntensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) plans of five head-and-neck (HN) and five prostate patients were selected for the patient-specific QC. These plans were generated using the Eclipse TPS v11·0 (Varian Medical Systems, Inc., Palo Alto, CA, USA) 6 MV X-ray from a Varian TrueBeam linear accelerator (Varian Medical Systems, Inc.) for each case. Each IMRT and VMAT plans were measured by two-dimensional (2D) ion chamber arrays (I’matriXX) and electronic portal imaging devices (EPID), respectively. The passing rates of the dosimetric tools were calculated using criteria of 3%/3 mm.ResultsThe average passing rates (±SD) of I’matriXX for prostate and HN were 97·9±0·76 and 98·88±0·24, respectively. For VMAT verification, the average passing rates of EPID for prostate for arc1 and arc2 were 96·15±0·49 and 97·8±0·70, respectively; similarly, for HN the rates were 97·85±0·63 and 97·2±0·56, respectively.ConclusionThe results showed that both the dosimeters can be used in patient-specific QC, although the EPID-based IMRT and VMAT QC is more advantageous in terms of time-saving and ease of use. Hence, for patient-specific QC, one can use the ion chamber arrays (I’matriXX) or EPID in hospital, but the systems need to be cross-checked.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.